BINDING MODES OF LONG-CHAIN ARYLPIPERAZINES TO 5-HT1A, 5-HT2A AND 5-HT7 RECEPTORS

Authors

  • Anna Bielenica Katedra i Zakład Chemii Medycznej, I Wydział Lekarski Warszawski Uniwersytet Medyczny,
  • Jerzy Kossakowski Katedra i Zakład Chemii Medycznej, I Wydział Lekarski Warszawski Uniwersytet Medyczny,

DOI:

https://doi.org/10.56782/pps.67

Keywords:

docking, LCAPs, 5-HT1A receptor, 5-HT2A receptor and 5-HT7 receptor

Abstract

The objective of this article is a presentation of selected docking models of long-chain arylpiperazines to 5-HT1A, 5-HT2A and 5-HT7 receptors. The most important types of interactions stabilizing the ligand-receptor complex were described. Several hypotheses proposed on the basis of homological modeling were discussed. In order to determine conformations of known alkyl- and alkoxypiperazinyl ligands, structural data from Cambridge Structural Database were analyzed.

Downloads

Download data is not yet available.

References

Sylte I., Bronowska A., Dahl S.G., Eur. J. Pharmacol. 2001, 416, 33

Kapetanovic I.M.,Chem. Biol. Interact. 2008, 171, 165 DOI: https://doi.org/10.1016/j.cbi.2006.12.006

Ishiguro M., ChemBioChem 2004, 5, 1210 DOI: https://doi.org/10.1002/cbic.200400068

Pardo L., Deupi X., Dölker N., Lopez-Rodriguez M.L., Campillo M., ChemBioChem 2007, 8, 19 DOI: https://doi.org/10.1002/cbic.200600429

Silverman R.B., Chemia organiczna w projektowaniu leków, WNT, Warszawa, 2007

Giacovazzo C., Fundaments of Crystallography, Oxford University Press, USA, 2002

Allen F. H., Acta Cryst., 2002, B58, 380 DOI: https://doi.org/10.1107/S0108768102003890

The Cambridge Structural Dabase, 2007, 5, 59

Siracusa M.A., Salerno L., Modica M.N., Pittala V., Romeo G., Amato M.E., Nowak M., Bojarski A.J., Mereghetti I., Cagnotto A., Mennini T., J. Med. Chem., 2008, 51, 4529 DOI: https://doi.org/10.1021/jm800176x

Paluchowska M.H., Bojarski A.J., Charakchieva-Minol S., Wesołowska A., Eur. J. Med. Chem., 2002, 37, 273 DOI: https://doi.org/10.1016/S0223-5234(01)01312-5

Nichols D. E., Nichols Ch.D., Chem. Rev. 2008, 108, 1614 DOI: https://doi.org/10.1021/cr078224o

Kitson S.L., Curr. Pharm. Des. 2007, 13, 2621 DOI: https://doi.org/10.2174/138161207781663000

Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., Miyano M., Science. 2000, 289, 739 DOI: https://doi.org/10.1126/science.289.5480.739

Nowak M., Kołaczkowski M., Pawłowski M., Bojarski A.J,, J. Med. Chem., 2006, 49, 205 DOI: https://doi.org/10.1021/jm050826h

Bronowska A., Leś A., Chilmonczyk Z., Filipek S., Edvardsen Ø., Østensen R., Bioorg. Med. Chem. 2001, 9, 881 DOI: https://doi.org/10.1016/S0968-0896(00)00307-2

Strzelczyk A.A., Jarończyk M., Chilmonczyk Z., Mazurek A.P., Chojnacka-Wójcik E., Sylte I., Biochem. Pharmacol. 2004, 67, 2219 DOI: https://doi.org/10.1016/j.bcp.2004.02.026

Sylte I., Bronowska A., Dahl S.G., Europ. J. Pharm., 2001, 416, 33 DOI: https://doi.org/10.1016/S0014-2999(01)00860-3

López-Rodríguez M.L., Morcillo M.J., Fernández E., Benhamú B., Tejada I., Ayala D., Viso A., Campillo M., Pardo L., Delgado M., Manzanares J., Fuentes J.A., J. Med. Chem. 2005, 48, 2548 DOI: https://doi.org/10.1021/jm048999e

López-Rodríguez M.L., Morcillo M.J., Fernández E., Rosado M.L., Pardo L., Schaper K., J. Med. Chem. 2001, 44, 198 DOI: https://doi.org/10.1021/jm000930t

López-Rodríguez M.L., Vicente B., Deupi X., Barrondo S., Olivella M., Morcillo M.J., Behamú B., Ballesteros J.A., Sallés J., Pardo L., Mol. Pharmacol. 2002, 62, 15 DOI: https://doi.org/10.1124/mol.62.1.15

López-Rodríguez M.L., Morcillo M.J., Fernández E., Benhamú B., Tejada I., Ayala D., Viso A., Olivella M., Pardo L., Delgado M., Manzanares J., Fuentes J.A., Bioorg. Med. Chem. Lett. 2003, 13, 1429

Seeber M., De Benedetti P.G., Fanelli F., J. Chem. Inf.Comput.Sci., 2003, 43, 1520 DOI: https://doi.org/10.1021/ci034069c

Zlatović M., Sukalovic V.V., Schneider Ch., Roglic G.M., Bioorg. Med. Chem. 2006, 14, 2994 DOI: https://doi.org/10.1016/j.bmc.2005.12.023

Becker O.M., Dhanoa D.S., Marantz Y., Chen D., Shacham S., Cheruku S., Heifetz A., Mohanty P., Fichman M., Sharadendu A., Nudelman R., Kauffman M., Noiman S., J. Med. Chem. 2006, 49, 3116 DOI: https://doi.org/10.1021/jm0508641

Zlatović M.V., Šukalivić V.V., Kostić-Rajačić S., Andić D.B, Roglić GM, J. Serb. Chem. Soc., 2006, 71, 1125

Brea J., Rodrigo J., Carrieri A., Sanz F., Cadavid M.I., Enguix M.J., Villazón M., Mengod G., Yolanda Caro, Masaguer Ch.F., Raviña E., Centeno N.B., Carotti A., Loza M.I., J. Med. Chem. 2002, 45, 54 DOI: https://doi.org/10.1021/jm011014y

Roth B.L., Choudhary M.S., Khan N., Uluer A.Z., J. Pharmacol. Exp. Ther. 1997, 280, 576

Shapiro D.A., Kristiansen K., Kroeze W.K., Roth B.L., Mol. Pharmacol, 2000, 58, 877 DOI: https://doi.org/10.1124/mol.58.5.877

Ebersole B.J., Visiers I., Weinstein H., Sealfon S.C., Mol. Pharmacol. 2003, 63, 36 DOI: https://doi.org/10.1124/mol.63.1.36

Klabunde T., Evers A., Chembiochem. 2005, 6, 876 DOI: https://doi.org/10.1002/cbic.200400369

Rowley M., Bristow L. J., Hutson P. H., J. Med. Chem. 2001, 44, 477 DOI: https://doi.org/10.1021/jm0002432

Mahe C., Bernhard M., Bobirnac I., Keser C., Loetscher E., Feuerbach D., Dev K.K., Schoeffter P., Br. J. Pharmacol. 2004, 143, 404 DOI: https://doi.org/10.1038/sj.bjp.0705936

Leopoldo M., Curr. Med. Chem. 2004, 11, 629 DOI: https://doi.org/10.1191/0969733004ne746xx

Hoyer D., Hannon J.P., Martin G.R., Pharm. Biochem. Behav. 2002, 71, 533 DOI: https://doi.org/10.1016/S0091-3057(01)00746-8

Kołaczkowski M., Nowak M., Pawłowski M., Bojarski A.J. – J. Med. Chem. 2006, 49, 6732 DOI: https://doi.org/10.1021/jm060300c

Lopez-Rodriguez M. L., Porras E., Morcillo M. J., Benhamu B., Soto L. J., Lavandera J. L., Ramos J. A., Olivella M., Campillo M., Pardo L., J. Med. Chem. 2003, 46, 5638 DOI: https://doi.org/10.1021/jm030841r

Vermeulen E. S., Schmidt A. W., Sprouse J. S., Wikstrom H. V., Grol C. J., J. Med. Chem. 2003, 46, 5365 DOI: https://doi.org/10.1021/jm030826m

Downloads

Published

2010-03-23

Issue

Section

Articles

How to Cite

BINDING MODES OF LONG-CHAIN ARYLPIPERAZINES TO 5-HT1A, 5-HT2A AND 5-HT7 RECEPTORS. (2010). Prospects in Pharmaceutical Sciences, 8(2), 13-21. https://doi.org/10.56782/pps.67

Similar Articles

11-20 of 61

You may also start an advanced similarity search for this article.